Organisation
- Acronym
- BMFTR
- Role
- Partner
- Country
- DE
- Address
- Kapelle-Ufer 1D-10117 Berlin
- Website
- https://www.bmbf.de/EN/Home/home_node.html
Partner
DE
DE
Federal Ministry of Research, Technology and Space
BMFTR
Programme phases
4
TRANSCAN-1
2011–2014
View phase
TRANSCAN-2
2015–2021
View phase
TRANSCAN-3
2021–2027
View phase
TRANSCAN-4
2026–2031
View phase
Funding participation
Joint calls funded by this organisation.
Funded projects
Projects linked to this funding organisation.
ABC-Cancer
Airborne Biomarkers for Colorectal Cancer
JTC 2016
View project
ARREST
Approaching recurrence and resistance mechanisms in esophagogastric adenocarcinomas from the prospective MEMORI trial
JTC 2014
View project
ASAMET
A randomized, 2x2 biomarker prevention trial of low-dose aspirin and metformin in colon cancer patients
JTC 2013
View project
ATRTPepVac
Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions
JTC 2013
View project
BePrepared
Building an ex vivo complex tumour microenvironment platform for development of combination therapies and drug resistance studies in head neck cancer
JTC 2024
View project
BIALYMP
Bispecific antibodies in Lymphoma: Microenvironmental profiling to predict treatment response and uncover immunogenic resistance mechanisms
JTC 2021
View project
BileCanMet
Precision medicine in cholangiocarcinoma: accurate tools for early detection and identification of PRMT5 as a novel pharmacological target
JTC 2022
View project
Bio RaRE
K-RAS mutations and DNA repair function in NSCLC
JTC 2011
View project
Bio-PaC
Biomarkers of tumor recurrence in pancreatic cancer
JTC 2013
View project
BioEndoCar
Biomarkers for diagnosis and prognosis of endometrial carcinoma
JTC 2016
View project
BRCAddict
BRCAddict – Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors
JTC 2017
View project
CAR4PDAC
Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC
JTC 2022
View project
CCE Breast
Clinical Impact of Intratumor heterogeneity in metastatic breast cancer
JTC 2014
View project
CEVIR
Cancer evolution and identification of relapse-initiating cells.
JTC 2014
View project
CHRYSALIS
Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian Cancer through multiOMICS analysis
JTC 2021
View project
CLEARLY
Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection.
JTC 2016
View project
CTC-SCAN
Circulating Tumor Cells as Biomarker for Minimal Residual Disease in Prostate Cancer
JTC 2011
View project
DC2M-TAEC
Detection, Classification, Characterization and Treatment Monitoring of Tumors by Accessible Epigenetic Classification
JTC 2023
View project
DICE
Epigenomic regulation of cancer immunity by dietary intervention
JTC 2023
View project
DietINT
A randomized phase II study for tertiary prevention of squamocellular cancer of head and neck (SCCHN) with a dietary intervention
JTC 2013
View project
DRAMA
Defeating Recurrence and resistance in AML: Multigenomic Approaches to analyse heterogeneity
JTC 2014
View project
EPILUNAR
Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer
JTC 2023
View project
EpiMARK
An integrated approach for epigenetic risk assessment and biomarker development for breast cancer in prospective cohorts / Identifying early epigenetic predictors of breast cancer risk and their etiology determinants
JTC 2012
View project
EPIPROPER
Identifying EPIgenetic determinants and biomarkers of drug resistance via characterization of PROspective PERsister cells
JTC 2023
View project
EPI_T-ALL
Unveiling the Epigenetic Landscape and Therapeutic Implications of Epigenetic Modifiers in Human T-cell Leukemia Initiation and Progression
JTC 2023
View project
ERANET-PLL
Implementation of (epi)genetic and metabolic networks in the targeting of T-cell prolymphocytic leukemia
JTC 2017
View project
ESCEND
Detection of Early esophageal cancer by near-infrared fluorescence molecular endoscopy
JTC 2016
View project
ET-FES
Early prediction of efficacy of endocrine therapy in breast cancer: pilot study and validation with 18F Fluoroestradiol (FES) PET/CT
JTC 2011
View project
Euro MDS
An integrated european platform to conduct translational studies in myelodysplastic syndromes based on the EuroBloodNet infrastructure
JTC 2017
View project
EuroTCLym
Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets
JTC 2017
View project
EXPLORE-NB
Exploring the epigenetic neuroblastoma landscape to improve measurable disease monitoring, disease understanding and personalized treatment
JTC 2023
View project
FAMILIAL CANCER
Cancer prevention through improved familial risk assessment and gene discovery
JTC 2012
View project
FIRE-CLL
Fighting Resistance in CLL
JTC 2014
View project
FOCUS
Biomarkers related to folate-dependent one-carbon metabolism in CRC recurrence and survival
JTC 2013
View project
GCH-CLL
Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemia outcome and treatment resistance
JTC 2014
View project
GENMEL
Identification of genetic markers involved in development of metastases and second cancers in melanoma
JTC 2013
View project
GLIO-COMBO
Targeting tumor heterogeneity in pediatric high-grade gliomas
JTC 2024
View project
GRAN-T-MTC
Phase I clinical trial using a novel CCK-2/gastrin receptor-localizing radiolabelled peptide probe for personalized diagnosis and therapy of patiens with progressive or metastatic medullary thyroid carcinoma
JTC 2011
View project
HAPLO-IMMUNE
Validation of immune biomarkers predictive of clinical outcome after HLA-haploidentical hematopoietic stem cell transplantation for acute leukemia
JTC 2011
View project
HAVOC
Human avatar on chip for advancing personalized cancer therapies by integrating vascular and immune components in a Tumor-on-Chip model
JTC 2024
View project
HIGHCARE
High resolution project on prognosis and CARE of cancer patients
JTC 2013
View project
HLALOSS
New technologies for early detection of HLA loss leukemia relapse after allogeneic hematopoietic stem cell transplantation, and identification of relevant risk factors
JTC 2012
View project
HYDRA
Charting the epigenomic trajectory of progression towards metastatic colorectal cancer
JTC 2023
View project
iCC-Strat
Risk stratification and subtyping of intrahepatic cholangiocarcinoma for early detection of recurrence and response to immuno-therapy
JTC 2022
View project
IdeaTMEHCC
Identification of therapeutic targets using HCC DErived organoid Augmented with TME components.
JTC 2022
View project
IMMOSCAN
The role of IMMune OSteoclasts in CANcer – Implications for therapy
JTC 2021
View project
ImmuMet
Invigorating immunity against brain metastases in lung and breast cancer patients
JTC 2021
View project
iMMunocell
Single-cell immunophenotypic and transcriptomic profiling for minimally-invasive detection of early multiple myeloma
JTC 2016
View project
IMMUNOSCOR
Integrative cancer-immunology and Immunoscore for cancer classification and immunotherapies
JTC 2013
View project
ImPECT
Immune Cells as Predictors for Early Diagnosis and Chemotherapy Toxicity in Ovarian Cancer
JTC 2011
View project
ioAVATAR
Immune oncology Drug Discovery & Decision - Advanced ex Vivo Approach To Accelerate Response prediction for combined therapies in ovarian cancer
JTC 2024
View project
iParaCyts
Understanding and therapeutically exploiting the immunosuppressive paracrine signalling in the tumour microenvironment of metastatic lesions
JTC 2021
View project
LIQUIDHOPE
Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastoma
JTC 2017
View project
LUNGOIDS
Subtype-specific Lung Cancer Organoids based on artificial ECM for Precision Oncology: Closing the Gap Between Preclinical Models and Patient Care
JTC 2024
View project
Ma.Tr.OC
Identification of molecular therapeutic targets and diagnostic/prognostic biomarkers for Malignant Transformation of Osteochondromas
JTC 2012
View project
MAGNOLIA
MAppinG adaptatioN Of tripLe negative breast cancer microenvironments to ImmunotherApy
JTC 2021
View project
MATTO-GBM
Multimodality Artificial intelligence open-source Tools for Radiation Treatment Optimization in patients with Glioblastoma
JTC 2022
View project
MesaCapp
Mesalamine for Colorectal Cancer Prevention Program in Lynch syndrome
JTC 2012
View project
MetaboCCC
Metabolomic profiles throughout the continuum of colorectal cancer
JTC 2012
View project
METRICs
Metabolism/Metagenomics-based strategies for sensitization to Radio- and Immuno- therapy Combinations.
JTC 2024
View project
MOLCARUTUC
Comprehensive genomic characterization of upper urinary tract urothelial carcinoma and paired bladder recurrences
JTC 2017
View project
NanoEFEct
Nanoparticle-Enhanced molecular Fluorescence-Endoscopy for detection of early-stage colorectal adenocarcinomas
JTC 2012
View project
NExT
Establishing an algorithm for the early diagnosis and follow-up of patients with pancreatic neuroendocrine tumors
JTC 2017
View project
NIRBTEST
New strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles.
JTC 2016
View project
NK-4-GBM
Metabolically optimised NK cell therapies for Glioblastoma
JTC 2022
View project
NOVEL
Employing NGS technology for improved, non-invasive early detection, staging and prediction of progression in lymphoma patients
JTC 2016
View project
ONTHETRRAC
Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe
JTC 2014
View project
PaCaNano
Development of a pancreatic cancer drug-nanocarrier system selectively targeting tumour cells and tumour stroma to overcome treatment failure
JTC 2022
View project
PERIMMUNE
INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASES
JTC 2021
View project
PIXEL
Profiling and functional analysis of the Immune environment of eXtramedullary leukemia rELapses
JTC 2021
View project
PLASTIG
Tackling tumor heterogeneity and PLASTIcity as resistance mechanisms in Glioblastoma
JTC 2022
View project
PMTR-pNET
Predictive models of therapy response in pancreatic neuroendocrine tumors
JTC 2017
View project
PRECEDENCE
Genotype matched therapies in intrahepatic cholangiocarcinoma: a multi-pronged strategy for improving efficacy and combating resistance.
JTC 2022
View project
PREDICO
Defining Predictive Immunedeterminants of response to neoadjuvant Chemoradiation in Oesophageal adenocarcinoma
JTC 2021
View project
PREDICT
Personalized prevention of colorectal neoplasia by use of genetic variability for the prediction of efficacy and toxicity of treatment with COX-2 inhibitors and aspirin
JTC 2012
View project
PREDICt
Profiling radioREsistant Differentiated thyroId Cancer: genes, immunity, cancer stem cells and epithelial-mesenchymal transition
JTC 2017
View project
PREDICT-BC
Patient-derived models for the Research and Evaluation of Discovery and Innovation in Combination Therapies for Biliary Cancer
JTC 2024
View project
PROLIPSY
Early Detection of Prostate Cancer by Liquid Biopsies
JTC 2016
View project
PROMETOV
Proteogenomic and targeted metabolomic analysis of ovarian cancer heterogeneity and its contribution to recurrence and therapy resistance.
JTC 2014
View project
PROVABES
PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalised translational medicine
JTC 2011
View project
Pur-Ther
New immunotherapies targeting the key purinergic checkpoints in the tumor microenvironment
JTC 2021
View project
Quant-ALL
Automated, absolute quantification of MRD in ALL patients by droplet microfluidics, single DNA copy barcoding and IG/TR amplicon NGS
JTC 2017
View project
REACH
Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer
JTC 2023
View project
ReachGLIO
Reaching the heterogeneous vascular landscape of glioblastoma with multifunctional nanomedicines.
JTC 2022
View project
RISEBrain
Reverting immune suppression to elicit brain metastasis control
JTC 2021
View project
ROCSANbio
Anti-PD1 and Niraparib (PARPi) combination therapy in gynae carcinosarcoma: Identification of response-predictive biomarkers and resistance mechanisms
JTC 2017
View project
SARAH
Search for combinational therapy to target clonal haematopoiesis in solid malignancies
JTC 2024
View project
SCIE-PANC
Stromal Compartment and Immune Epigenome spatial networks to counter therapy evasion in PANcreatic Cancer
JTC 2023
View project
SCRAtCH
Microbiota-based screening of anal cancer in HIV-infected individuals
JTC 2016
View project
SIMMBAP
Systemic immunological determinants of tumor evolution and therapy response in BRCA-mutated pancreatic cancer
JTC 2022
View project
SmartCAR-T
SmartCAR-T - Reprogramming of the tumor microenvironment with modular engineered CAR-T cells to augment the efficacy of immunotherapy
JTC 2021
View project
SPELCASTER
Standardized Profiling of Epigenetic Loci for decentralized ClAssification of Sinonasal Tumors and idEntification of therapy Response markers
JTC 2023
View project
T-Plex EAC
T-Plex-Capture: Isolation of neoantigen-specific CD8+ T cell receptors for patient-specific immunotherapy in esophageal adenocarcinoma (EAC)
JTC 2022
View project
TACTIC
TArgeting Colon Tumor Initiating Cell heterogeneity
JTC 2014
View project
TALETE
TArgeting acute myeloid Leukemia immunosuppressive microEnvironment by combined IDO1 inhibiTion and PD-1 blockadE
JTC 2021
View project
TANGERINE
Artificial-intelligence-based end-to-end prediction of cancer immunotherapy response
JTC 2021
View project
TENACITY
TargEting the Nectin fAmily to boost Cancer ImmuniTY
JTC 2021
View project
TH4RESPONS
Clinical utility of tumour heterogeneity in triple negative breast cancer and high-grade serous ovarian carcinoma for prediction of therapy response
JTC 2014
View project
TORPEDO
Targeting Of Resistance in PEDiatric Oncology (TORPEDO)
JTC 2014
View project
TOSCANINI
TAD disruption and aberrant expression as leukemia metabolic vulnerabilities for novel combination therapy tests in a drug screening platform
JTC 2024
View project
TRANSCALL
Validation of the impact of genetic aberrations and host genetic variation in childhood acute lymphoblastic leukemia for integration into clinical practice
JTC 2011
View project
TRANSCALL-2
Integration of genetic biomarkers and early Minimal Residual Disease to improve risk stratification and cure in childhood Acute Lymphoblastic Leukemia
JTC 2016
View project
TRANsIBCCS
Development of a Comprehensive Risk Prediction Model for BRCA1 and BRCA2 mutation carriers
JTC 2012
View project
Triage-MDS
TRanslational Implementation of Genetic Evidence in the management of MDS
JTC 2012
View project
TumorOUT
Innovative mRNA vaccine against NSCLC: Designing a platform of targeted polymeric nanoparticles for efficient personalized therapy
JTC 2021
View project
UGI1
CD3 and CD20 lymphocytes infiltration to predict chemosensitivity in patients with triple negative breast cancer
JTC 2011
View project
VALPRAXIN
Validation of Aprataxin as a biomarker of response to Topoisomerase I inhibitors in cancer patient
JTC 2011
View project